EE200100433A - Klaritromütsiini, rasv- ja hüdrofiilse komponendisegu sisaldav farmatseutiline preparaat, meetod selle valmistamiseks ning kasutamine - Google Patents

Klaritromütsiini, rasv- ja hüdrofiilse komponendisegu sisaldav farmatseutiline preparaat, meetod selle valmistamiseks ning kasutamine

Info

Publication number: EE200100433A
Authority: EE; Estonia
Prior art keywords: fatty; mixture; preparation; hydrophilic constituents; pharmaceutical preparation
Prior art date: 1999-02-19

Application number

EEP200100433A

Other languages

English (en)

Inventor

Fercej Temeljotov Darja

Mohar Milojka

Salobir Mateja

Barbara Rebic Ljubomira

Opresnik Marko

Original Assignee

Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-19

Filing date

2000-02-17

Publication date

2002-12-16

2000-02-17 Application filed by Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. filed Critical Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D.

2002-12-16 Publication of EE200100433A publication Critical patent/EE200100433A/et

2011-06-15 Publication of EE05422B1 publication Critical patent/EE05422B1/et

Links

AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 title abstract 2
229960002626 clarithromycin Drugs 0.000 title abstract 2
239000000470 constituent Substances 0.000 title 1
238000000034 method Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
239000013543 active substance Substances 0.000 abstract 1
238000013270 controlled release Methods 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EEP200100433A 1999-02-19 2000-02-17 Klaritromtsiini, rasv- ja hdrofiilse komponendi segu sisaldav farmatseutiline preparaat, meetod selle valmistamiseks ning kasutamine EE05422B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SI9900039A SI20150A (sl)	1999-02-19	1999-02-19	Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina
PCT/SI2000/000002 WO2000048607A1 (en)	1999-02-19	2000-02-17	Directly compressible matrix for controlled release of single daily doses of clarithromycin

Publications (2)

Publication Number	Publication Date
EE200100433A true EE200100433A (et)	2002-12-16
EE05422B1 EE05422B1 (et)	2011-06-15

Family

ID=20432410

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100433A EE05422B1 (et)	1999-02-19	2000-02-17	Klaritromtsiini, rasv- ja hdrofiilse komponendi segu sisaldav farmatseutiline preparaat, meetod selle valmistamiseks ning kasutamine

Country Status (21)

Country	Link
EP (1)	EP1150686B1 (et)
AT (1)	ATE286736T1 (et)
AU (1)	AU776912B2 (et)
BG (1)	BG65324B1 (et)
CY (1)	CY1107454T1 (et)
CZ (1)	CZ302781B6 (et)
DE (1)	DE60017361T2 (et)
DK (1)	DK1150686T3 (et)
EE (1)	EE05422B1 (et)
ES (1)	ES2235834T3 (et)
HR (1)	HRP20010684B1 (et)
HU (1)	HUP0105481A3 (et)
PL (1)	PL196665B1 (et)
PT (1)	PT1150686E (et)
RS (1)	RS50298B (et)
RU (1)	RU2237480C2 (et)
SI (2)	SI20150A (et)
SK (1)	SK287525B6 (et)
TR (1)	TR200102396T2 (et)
UA (1)	UA74778C2 (et)
WO (1)	WO2000048607A1 (et)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200000054A2 (tr) *	2000-01-05	2001-08-21	Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇	Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6565882B2 (en)	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
IN192748B (et) *	2000-08-29	2004-05-15	Ranbaxy Lab Ltd
US6541014B2 (en)	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20020068078A1 (en)	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US6673369B2 (en)	2001-08-29	2004-01-06	Ranbaxy Laboratories Limited	Controlled release formulation
CA2405918A1 (en) *	2001-10-01	2003-04-01	Ind-Swift Limited	Controlled release macrolide pharmaceutical formulations
SE0103369D0 (sv) *	2001-10-09	2001-10-09	Astrazeneca Ab	Pharmaceutical formulation
CA2465405A1 (en)	2001-11-02	2003-05-08	Wockhardt Limited	Controlled release compositions for macrolide antimicrobial agents
CA2481271A1 (en) *	2002-04-03	2003-10-09	Ranbaxy Laboratories Limited	Clarithromycin formulations having improved bioavailability
US20040115262A1 (en) *	2002-07-29	2004-06-17	Frank Jao	Formulations and dosage forms for controlled delivery of topiramate
US20060083759A1 (en) *	2002-07-17	2006-04-20	Aleksander Resman	Stabilization of the profile of release of active substances from a formulation
US20050232995A1 (en)	2002-07-29	2005-10-20	Yam Nyomi V	Methods and dosage forms for controlled delivery of paliperidone and risperidone
AU2004264356B2 (en)	2003-08-12	2011-01-27	Shionogi, Inc.	Antibiotic product, use and formulation thereof
WO2005023221A1 (en) *	2003-09-05	2005-03-17	Ranbaxy Laboratories Limited	Clarithromycin formulations having improved biovailability
RU2268051C2 (ru) *	2003-12-15	2006-01-20	Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское"	Лекарственная форма, обладающая бактериостатическим действием, и способ ее изготовления
US7943585B2 (en) *	2003-12-22	2011-05-17	Sandoz, Inc.	Extended release antibiotic composition
BRPI0508743A (pt) *	2004-03-24	2008-01-22	Lupin Ltd	composição farmacêutica com uma liberação estendida de eritromicina ou um derivado da mesma, método para o uso de uma composição farmacêutica e processo para a preparação de uma composição farmacêutica
EP2283824B1 (en)	2009-07-30	2017-04-19	Special Products Line S.p.A.	Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4331803A (en) *	1980-06-04	1982-05-25	Taisho Pharmaceutical Co., Ltd.	Novel erythromycin compounds
JPS60163823A (ja) *	1984-02-03	1985-08-26	Taisho Pharmaceut Co Ltd	経口投与製剤
JPS60214796A (ja) *	1984-04-06	1985-10-28	Taisho Pharmaceut Co Ltd	６−０−メチルエリスロマイシン類の製法
JPS63188621A (ja) *	1987-01-30	1988-08-04	Taisho Pharmaceut Co Ltd	矯味経口製剤
US4808411A (en) *	1987-06-05	1989-02-28	Abbott Laboratories	Antibiotic-polymer compositions
IL87219A0 (en) *	1987-08-07	1988-12-30	Abbott Lab	Erythromycin formulations for oral administration
JP2553882B2 (ja) *	1987-08-08	1996-11-13	富士写真光機株式会社	走査結像光学系
US5599556A (en) *	1991-12-31	1997-02-04	Abbott Laboratories	Prolamine coatings for taste masking
CA2182282C (en) *	1994-02-16	2006-04-18	Jacqueline E. Briskin	Process for preparing fine particle pharmaceutical formulations

1999
- 1999-02-19 SI SI9900039A patent/SI20150A/sl not_active IP Right Cessation
2000
- 2000-02-17 WO PCT/SI2000/000002 patent/WO2000048607A1/en not_active Ceased
- 2000-02-17 SI SI200030647T patent/SI1150686T1/xx unknown
- 2000-02-17 RS YUP-592/01A patent/RS50298B/sr unknown
- 2000-02-17 HU HU0105481A patent/HUP0105481A3/hu unknown
- 2000-02-17 EP EP00905514A patent/EP1150686B1/en not_active Expired - Lifetime
- 2000-02-17 AU AU27049/00A patent/AU776912B2/en not_active Ceased
- 2000-02-17 TR TR2001/02396T patent/TR200102396T2/xx unknown
- 2000-02-17 HR HR20010684A patent/HRP20010684B1/xx not_active IP Right Cessation
- 2000-02-17 AT AT00905514T patent/ATE286736T1/de active
- 2000-02-17 PT PT00905514T patent/PT1150686E/pt unknown
- 2000-02-17 ES ES00905514T patent/ES2235834T3/es not_active Expired - Lifetime
- 2000-02-17 CZ CZ20012964A patent/CZ302781B6/cs not_active IP Right Cessation
- 2000-02-17 SK SK1197-2001A patent/SK287525B6/sk not_active IP Right Cessation
- 2000-02-17 RU RU2001125667A patent/RU2237480C2/ru not_active IP Right Cessation
- 2000-02-17 PL PL350419A patent/PL196665B1/pl unknown
- 2000-02-17 EE EEP200100433A patent/EE05422B1/et not_active IP Right Cessation
- 2000-02-17 UA UA2001096230A patent/UA74778C2/uk unknown
- 2000-02-17 DE DE60017361T patent/DE60017361T2/de not_active Expired - Lifetime
- 2000-02-17 DK DK00905514T patent/DK1150686T3/da active
2001
- 2001-09-19 BG BG105914A patent/BG65324B1/bg unknown
2005
- 2005-03-10 CY CY20051100330T patent/CY1107454T1/el unknown

Also Published As

Publication number	Publication date
DE60017361T2 (de)	2005-12-22
DE60017361D1 (de)	2005-02-17
BG105914A (bg)	2002-05-31
ES2235834T3 (es)	2005-07-16
AU776912B2 (en)	2004-09-23
EP1150686B1 (en)	2005-01-12
AU2704900A (en)	2000-09-04
HUP0105481A2 (hu)	2002-05-29
UA74778C2 (en)	2006-02-15
CY1107454T1 (el)	2012-12-19
RU2237480C2 (ru)	2004-10-10
EE05422B1 (et)	2011-06-15
SK11972001A3 (sk)	2002-02-05
RS50298B (sr)	2009-09-08
WO2000048607A1 (en)	2000-08-24
SI20150A (sl)	2000-08-31
DK1150686T3 (da)	2005-04-04
HUP0105481A3 (en)	2003-04-28
CZ302781B6 (cs)	2011-11-02
EP1150686A1 (en)	2001-11-07
PT1150686E (pt)	2005-05-31
CZ20012964A3 (cs)	2002-01-16
SK287525B6 (sk)	2011-01-04
HRP20010684A2 (en)	2002-10-31
TR200102396T2 (tr)	2002-01-21
PL350419A1 (en)	2002-12-16
YU59201A (sh)	2004-07-15
SI1150686T1 (en)	2005-06-30
BG65324B1 (bg)	2008-02-29
PL196665B1 (pl)	2008-01-31
ATE286736T1 (de)	2005-01-15
HRP20010684B1 (hr)	2011-01-31

Legal Events

Date	Code	Title	Description
2005-08-15	HC1A	Change of owner name
2009-02-16	HC1A	Change of owner name
2013-10-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20130217

Publication	Publication Date	Title
EE200100433A (et)	2002-12-16	Klaritromütsiini, rasv- ja hüdrofiilse komponendisegu sisaldav farmatseutiline preparaat, meetod selle valmistamiseks ning kasutamine
BR0312633A (pt)	2005-07-19	Composto, uso do composto, composição farmacêutica, processo para a preparação de um composto
WO2001076370A3 (en)	2002-03-28	Anthelmintic combinations
NO20025621D0 (no)	2002-11-22	Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
CA2366702A1 (en)	2000-10-12	Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
BRPI0409185A (pt)	2006-04-11	formulações veterinárias anti-helmìnticas tópicas
PE20020968A1 (es)	2002-12-10	Preparados de insulina exentos de zinc y pobres en zinc, con estabilidad mejorada
EP1810715A3 (en)	2009-12-16	Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity
NZ515230A (en)	2004-01-30	Fast-dispersing dosage forms containing fish gelatin
BR9912975A (pt)	2001-09-25	Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
BR0309004A (pt)	2005-02-01	Matriz para liberação gradual, invariante e independente dos compostos ativos
NZ513810A (en)	2004-02-27	Compositions and methods for improved delivery of hydrophobic therapeutic agents
WO2003002136A3 (en)	2004-03-04	Stable formulation of modified glp-1
AU2001296865A1 (en)	2002-03-22	(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
DK1056454T3 (da)	2003-08-18	Anvendelse af makrolidforbindelser til behandling af glaukom
BR0111678A (pt)	2003-06-03	Composições medicinais contendo derivados de propenona
ES2086022T3 (es)	1996-06-16	Composiciones estables para administracion parenteral y su uso.
ES2157886T3 (es)	2001-09-01	Composiciones tensioactivas y procedimientos.
NO20066070L (no)	2007-02-27	Fremgangsmate for formulering av hurtig-dispergerende former omfattende minst et fiske gelatin valgt pa grunnlag av molekylvekt
CY1108145T1 (el)	2013-03-13	Σταθερες συνθεσεις για παρεντερικη χορηγηση
CA2153549A1 (fr)	1996-01-13	Nouveau derive de benzothiadiazine, son procede de preparation et les compositions pharmeceutiques qui le contiennent
WO2002024665A8 (en)	2002-06-06	Arylalkane-sulfonamides having endothelin-antagonist activity
BR0008739A (pt)	2001-12-26	Composições de liberação controlada debeta-histina
HRP20050342B1 (hr)	2013-11-08	Farmaceutska formulacija olanzapina
KR20150084839A (ko)	2015-07-22	기제 및 피부 외용제